GKB Ophthalmics

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE265D01015
  • NSEID: GKB
  • BSEID: 533212
INR
60.84
1.2 (2.01%)
BSENSE

Oct 09

BSE+NSE Vol: 202

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
GKB Ophthalmics
Centenial Surgic
Bandaram Pharma
Deccan Healthcar
N G Industries
Tejnaksh Health.
Chennai Meena
KMS Medisurgi
Royal Sense
Samsrita Labs
Galaxy Medicare
Why is GKB Ophthalmics Ltd ?
1
Weak Long Term Fundamental Strength with a 8.05% CAGR growth in Operating Profits over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -0.04
  • The company has been able to generate a Return on Equity (avg) of 1.63% signifying low profitability per unit of shareholders funds
2
Risky - Negative Operating Profits
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -4.81%, its profits have risen by 42.6%
3
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -4.81% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to GKB Ophthalmics should be less than 10%
  2. Overall Portfolio exposure to Healthcare Services should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is GKB Ophthalmics for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
GKB Ophthalmics
-7.72%
-0.07
65.81%
Sensex
-11.8%
-0.49
12.94%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
18.20%
EBIT Growth (5y)
46.47%
EBIT to Interest (avg)
0.30
Debt to EBITDA (avg)
5.54
Net Debt to Equity (avg)
0.13
Sales to Capital Employed (avg)
1.33
Tax Ratio
3.50%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
1.79%
ROCE (avg)
-0.62%
ROE (avg)
1.54%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
6
Industry P/E
41
Price to Book Value
0.58
EV to EBIT
5.14
EV to EBITDA
3.56
EV to Capital Employed
0.63
EV to Sales
0.25
PEG Ratio
0.04
Dividend Yield
NA
ROCE (Latest)
9.03%
ROE (Latest)
5.68%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

17What is working for the Company
PAT(Latest six months)

Higher at Rs 2.69 cr

ROCE(HY)

Highest at 11.76%

NET SALES(9M)

Higher at Rs 119.62 cr

-3What is not working for the Company
NET SALES(Q)

At Rs 33.04 cr has Fallen at -11.3% (vs previous 4Q average

CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 4.90 cr

Loading Valuation Snapshot...
Here's what is working for GKB Ophthalmics
Profit After Tax (PAT) - Latest six months
At Rs 2.69 cr has Grown at 158.86%
Year on Year (YoY)
MOJO Watch
PAT trend is very positive

PAT (Rs Cr)

Profit After Tax (PAT) - Latest six months
Higher at Rs 2.69 cr
than preceding 12 month period ended Jun 2026 of Rs -2.23 cr
MOJO Watch
In the half year the company has already crossed PAT of the previous twelve months

PAT (Rs Cr)

Here's what is not working for GKB Ophthalmics
Net Sales - Quarterly
At Rs 33.04 cr has Fallen at -11.3% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 37.27 Cr
MOJO Watch
Near term sales trend is very negative

Net Sales (Rs Cr)

Cash and Cash Equivalents - Half Yearly
Lowest at Rs 4.90 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents